Lansoprazol Ratiopharm

Lansoprazole, the active ingredient in Lansoprazol Ratiopharm, is a proton pump inhibitor presented as oral tablets for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcers and related disorders.

GNH USA supplies Lansoprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazol Ratiopharm is a proton pump inhibitor indicated for several acid‑related gastrointestinal conditions. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal healing and reduces recurrence. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients on chronic NSAID therapy.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Abdominal pain: discomfort or cramping. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions: anaphylaxis, angioedema, or rash. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Hepatic enzyme elevation: increased ALT/AST levels. - Hypomagnesemia: low serum magnesium with prolonged use. - Interstitial nephritis: kidney inflammation presenting with renal dysfunction.

Before initiating Lansoprazol Ratiopharm, consider the following precautions. - Renal function assessment: adjust use in patients with severe renal impairment. - Magnesium monitoring: check serum magnesium during long‑term therapy. - Elderly patients: use cautiously as they may be more susceptible to adverse effects. - Discontinuation: avoid abrupt cessation after prolonged use to prevent rebound acid hypersecretion. - Concomitant medications: review other drugs that may interact with acid suppression. - Store at below 25°C: keep in the original pack, protect from moisture.

Lansoprazol Ratiopharm may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clarithromycin: may increase lansoprazole plasma concentrations. - Ketoconazole: reduced absorption of ketoconazole when gastric pH is increased. - Atazanavir: decreased atazanavir exposure leading to subtherapeutic levels.

Moderate Interactions (Monitor Closely): - Digoxin: potential increase in digoxin levels; monitor serum concentrations. - Methotrexate: reduced clearance may raise methotrexate toxicity; monitor renal function and drug levels.